Synopsis: Wockhardt Limited has executed a structural pivot away from commoditised generics, concentrating its operating model across novel antibiotics, diabetes biosimilars, and a profitable base pharma business with the US FDA-approved Zaynich (Cefepime-Zidebactam)...
Synopsis: Healthcare stock surged 12 percent after FY26 results, driven by strong biotech growth, emerging market expansion, margin improvement, and a turnaround in profitability to Rs 199 crore PAT. The share of this company, which focuses on pharmaceutical...
In technical analysis, a Death Crossover is considered a bearish indicator signaling possible price declines. This pattern forms when a short-term moving average, commonly the 50-day, crosses below a long-term moving average, such as the 200-day. It reflects weakening...
